Apigenin is a plant flavonoid found in chamomile, parsley, and celery that has drawn research interest for its effects on anxiety, sleep, and cancer cell biology. As its popularity as a supplement grows, a reasonable question arises: does apigenin affect the thyroid gland or thyroid hormone metabolism? The honest answer is that human trial data are essentially absent, but a body of cell-culture and animal work—alongside broader research on the flavonoid class—raises questions worth understanding before you supplement.
The thyroid gland regulates metabolism, energy, temperature, and mood through two main hormones: thyroxine (T4) and triiodothyronine (T3). Disrupting the enzymes and transporters that produce and distribute these hormones can have wide-ranging consequences. Because several dietary flavonoids have shown measurable interactions with thyroid biology in laboratory settings, it is worth examining whether apigenin specifically belongs in that conversation—and being honest about where the evidence ends.
Key Takeaways
- The flavonoid family to which apigenin belongs has documented interactions with thyroid peroxidase, iodide uptake, and thyroid hormone transport in cell and animal models [3]; apigenin-specific human thyroid data are currently absent.
- In vitro evidence suggests certain flavonoids can inhibit TPO and influence iodide handling via NIS [PMID 15080787, PMID 18174954], but translating these findings to clinical thyroid suppression at supplement doses requires human study that does not yet exist.
- In one cell study, apigenin’s effects on cancer cell viability and senescence persisted in the presence of L-thyroxine, suggesting its mechanism was independent of thyroid hormone signaling in that model [5].
- Quercetin, a structurally related flavonoid, has shown inhibition of thyroid-restricted gene expression in cell research [4]; apigenin’s structural differences do not guarantee a different outcome, only a different—and less studied—profile.
- People with existing thyroid conditions or those on levothyroxine, antithyroid drugs, or thyroid-sensitive medications should consult a physician before using concentrated apigenin supplements.
Flavonoids as a Class and Thyroid Biology
Apigenin belongs to the flavone subclass of flavonoids—polyphenols that share a characteristic two-ring carbon skeleton and are widely distributed in plant foods. Research on the flavonoid class as a whole has identified several mechanisms by which these compounds can interact with thyroid physiology, including inhibition of thyroid peroxidase (TPO), interference with the sodium-iodide symporter (NIS), and competition with thyroid hormones at binding proteins and cellular receptors. A 2011 review examining flavonoids and thyroid function noted that multiple compounds in this family show activity at thyroid-relevant targets in cell and animal models [3].
This class-level finding is important context. Not every flavonoid behaves identically—quercetin, genistein, and apigenin each have distinct binding affinities, metabolic fates, and tissue distribution profiles. However, when a structural family shows consistent thyroid interactions, the member compounds deserve individual scrutiny rather than an assumption of safety based on dietary familiarity.
Thyroid Peroxidase Inhibition: A Mechanism to Understand
Thyroid peroxidase is the enzyme responsible for oxidizing iodide and incorporating it into thyroglobulin to produce T4 and T3. TPO inhibition is one route by which goitrogenic compounds suppress thyroid hormone production. Research examining endocrine-disrupting chemicals has helped map this pathway: combined in vitro and in vivo screening studies have identified structural features that predict thyroid peroxidase inhibitory potency, with polyphenolic compounds appearing in that literature as candidates for TPO interaction [2].
Whether apigenin reaches concentrations in thyroid tissue sufficient to meaningfully inhibit TPO at normal dietary or supplemental intakes is unknown. Laboratory models use isolated enzymes or cell lines at concentrations that may not reflect in vivo tissue exposure. This is a critical gap: demonstrable in vitro activity does not equal clinical thyroid suppression, and no human study has measured apigenin’s effect on serum TSH, T3, or T4 in supplemented individuals.
Iodide Uptake and the Sodium-Iodide Symporter
Iodide must be actively transported into thyroid follicular cells via the sodium-iodide symporter before it can be incorporated into thyroid hormone. A study using a NIS-transfected follicular thyroid carcinoma cell line found that natural flavonoids produced differential effects on cell growth and iodide content, with distinct compounds showing varying degrees of influence on NIS-mediated iodide accumulation [1]. This suggests that flavonoid effects on thyroid iodide handling are compound-specific rather than uniform across the class.
For apigenin specifically, NIS-focused data are limited. The significance of any in vitro NIS effect also depends on whether apigenin achieves meaningful thyroid tissue concentrations in a living system—something that has not been demonstrated in human pharmacokinetic studies with a thyroid-distribution focus. Extrapolating a cell-culture NIS finding to a clinical recommendation would be premature given current evidence.
Thyroid Hormone Uptake and Pituitary Signaling
Thyroid hormones must enter target cells via membrane transporters to exert their biological effects, and those transporters can be modulated by exogenous compounds. Research examining drug effects on triiodothyronine (T3) uptake in rat anterior pituitary cells in vitro found that certain compounds interfered with cellular T3 uptake at this level [6]. Pituitary sensitivity to circulating T3 is central to the TSH feedback loop that governs ongoing thyroid hormone production.
If a compound reduced T3 uptake in pituitary cells, the pituitary might perceive lower T3 availability and respond by elevating TSH output, potentially over-stimulating the thyroid. This hypothetical mechanism remains speculative for apigenin specifically—the cited work examined multiple compounds, and the direct relevance to apigenin requires careful reading of the primary source. The broader takeaway is that thyroid hormone transport is a pharmacologically tractable target, and flavonoid-class compounds have shown activity at related sites.
Apigenin in Thyroid-Adjacent Cancer Research
Some of the most targeted apigenin-thyroid research sits within oncology rather than endocrinology. A study investigating natural flavonoids in NIS-transfected thyroid carcinoma cells was explicitly framed around the thyroid cancer context, examining both cell growth and iodide handling in response to flavonoid exposure [1]. Separately, research on apigenin in colorectal cancer cells tested whether thyroid hormone co-exposure altered apigenin’s antiproliferative activity—finding that apigenin-mediated changes in cell viability and senescence were maintained even in the presence of L-thyroxine [5]. This suggests that, at least in that cancer cell model, apigenin’s mechanism of action was not substantially overridden by thyroid hormone signaling.
These are cell-culture findings in malignant cell lines, not healthy thyroid tissue, and they cannot be used to draw conclusions about apigenin’s effects on thyroid hormone production or metabolism in healthy people. The cancer biology literature exploring apigenin is active and growing, but its direct thyroid relevance remains indirect until controlled studies in healthy thyroid models are available.
Comparing Apigenin to Better-Studied Flavonoids
Among dietary flavonoids, quercetin has the most extensive thyroid-specific research. A 2014 study found that quercetin inhibited expression of thyroid-restricted genes and measurably reduced thyroid function markers in cell models, raising concern about high-dose quercetin supplementation in people with borderline thyroid function [4]. Quercetin and apigenin share the flavonoid backbone but differ in hydroxylation pattern: apigenin lacks quercetin’s 3′-hydroxyl and 3-hydroxyl groups, which alter binding affinity at various enzyme active sites.
This structural difference means that quercetin’s documented thyroid effects cannot be directly transferred to apigenin—but they also cannot be dismissed on structural grounds alone. The broader pattern in the flavonoid literature is that these compounds interact with thyroid biology in ways that vary by structure, concentration, and physiological context [3]. Apigenin has simply not been studied as thoroughly at the thyroid level, leaving genuine uncertainty rather than evidence of safety.
🛒 Where to Buy Apigenin
- Momentous Momentous ApigeninLab-tested / studied
capsules, 50 mg per capsule — Andrew Huberman’s publicly recommended brand; NSF Certified for Sport; single-ingredient, no fillers - Double Wood Supplements Apigenin 50mg
capsules, 50 mg per capsule, 120 count — High-volume value pick; third-party tested for purity; frequently top-ranked on Amazon - Nutricost Apigenin 50mg
capsules, 50 mg per capsule, 120 count — FDA-registered facility; gluten-free, non-GMO; competitive price-per-dose - Swanson Apigenin 50mg
capsules, 50 mg per capsule, 90 count — Established supplement brand; GMP-certified manufacturing; widely available, low cost
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
All thyroid-relevant evidence for apigenin currently comes from in vitro models and indirect findings; no human clinical trial has assessed its impact on thyroid hormone levels or thyroid function tests, so the true risk in people—particularly those with thyroid disease or on levothyroxine, antithyroid drugs, or thyroid-sensitive medications—is unknown. These statements have not been evaluated by the FDA; apigenin is not intended to diagnose, treat, cure, or prevent any disease, and this article is informational, not medical advice.
Frequently Asked Questions
Does apigenin affect thyroid hormone levels?
No published human trial has measured apigenin’s effect on TSH, T4, or T3 in supplemented individuals. Cell and animal research on flavonoids as a class has identified potential interactions with thyroid peroxidase, iodide symporter activity, and thyroid hormone transport [3], but whether apigenin reaches thyroid-relevant concentrations in vivo at typical supplement doses remains unstudied.
Can apigenin inhibit thyroid peroxidase?
TPO inhibition has been identified as a mechanism through which certain polyphenolic compounds interact with the thyroid in laboratory screening studies [2]. Apigenin has not been specifically confirmed as a potent TPO inhibitor in peer-reviewed literature included in this review. In vitro enzyme inhibition at high concentrations does not reliably predict clinically significant suppression of thyroid hormone production at the doses found in dietary supplements.
Is apigenin safe for people with hypothyroidism?
There is no human safety data specifically addressing apigenin supplementation in hypothyroid individuals. Because dietary flavonoids have shown thyroid-relevant activity in laboratory settings [3], and because hypothyroid individuals already have reduced thyroid reserve, caution is warranted. Anyone on levothyroxine or other thyroid medications should discuss apigenin supplementation with their prescribing physician before starting.
How does apigenin compare to quercetin for thyroid safety?
Quercetin has more direct thyroid research, including a cell-model study demonstrating inhibition of thyroid-restricted gene expression and reduced thyroid function markers [4]. Apigenin and quercetin share the flavonoid backbone but differ in hydroxylation pattern, which changes binding affinity at enzyme targets. Quercetin’s findings cannot be applied directly to apigenin—but apigenin’s structural difference does not provide a documented thyroid safety advantage, only a less studied profile.
Does thyroid hormone affect how apigenin works?
In one cell experiment, apigenin’s antiproliferative effects on colorectal cancer cell viability and senescence were maintained even when L-thyroxine was present in the culture medium [5], suggesting that thyroid hormone did not override apigenin’s mechanism in that model. This finding pertains to cancer cell biology and does not address whether apigenin alters thyroid hormone production or metabolism in healthy thyroid tissue.
What dose of apigenin raises thyroid concerns?
No threshold dose has been established for thyroid effects in humans. Dietary apigenin from chamomile tea or parsley arrives at concentrations far below those tested in cell studies. High-dose supplements—commonly sold at 50 mg or more per capsule—push intake into ranges that have not been evaluated for thyroid impact in human subjects, which is why individuals with thyroid conditions should seek medical guidance rather than self-experimenting with concentrated forms.
References
- Schröder-van der Elst JP et al. Differential effects of natural flavonoids on growth and iodide content in a human Na*/I- symporter-transfected follicular thyroid carcinoma cell line. European journal of endocrinology (2004). PMID 15080787
- Schmutzler C et al. Endocrine disruptors and the thyroid gland–a combined in vitro and in vivo analysis of potential new biomarkers. Environmental health perspectives (2007). PMID 18174954
- de Souza Dos Santos MC et al. Impact of flavonoids on thyroid function. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2011). PMID 21745527
- Giuliani C et al. The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2014). PMID 24447974
- Zohreh B et al. Apigenin-mediated Alterations in Viability and Senescence of SW480 Colorectal Cancer Cells Persist in The Presence of L-thyroxine. Anti-cancer agents in medicinal chemistry (2019). PMID 31272364
- Lim CF et al. Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitro. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (1996). PMID 8740939
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
